美国成年人被诊断患有糖尿病,并按年龄和保险类型注册医疗保险
Barbara H Bardenheier1, Steven Bloom1, Linda J Andes1
1Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, United States.
Preventive medicine reports
|July 21, 2025
概括
高风险人群更有可能注册医疗保险优势 (MA) 而不是传统的服务费 (FFS). 在MA和FFS计划之间,糖尿病护理满意度没有差异.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 糖尿病管理 糖尿病管理
- 医疗保险政策 医疗保险政策
背景情况:
- 了解美国医疗保险受益者,包括糖尿病患者和没有糖尿病患者的特点,对于医疗保健规划至关重要.
- 通过比较传统的服务费 (FFS) 和医疗保险优势 (MA) 注册模式,可以发现获得和利用方面的差异.
研究的目的:
- 根据年龄和保险类型 (FFS与MA) 对比美国医疗保险受益人的临床和社会经济特征.
- 根据年龄组和保险类型,比较受益人之间的糖尿病患病率.
- 为了评估FFS和MA注册糖尿病患者之间的护理满意度差异.
主要方法:
- 使用美国医疗保险当前受益者调查 (MCBS) 数据从2017-2022年进行的回顾性,横截面研究.
- 权重管理和调查数据的聚合分析.
- 后勤回归用于评估按保险类型对护理满意度的差异.
主要成果:
- 患糖尿病的高风险人群,包括非西班牙裔黑人,西班牙裔,低教育,低收入和双重资格受益者,更有可能参加MA.
- 参与MA的糖尿病受益人与FFS的受益人相比,在自我管理或医疗保健满意度方面没有显著差异.
- 对于MA与FFS入学的具体流行率,详细介绍了各个人口亚组的具体流行率.
结论:
- 患糖尿病风险较高的子组更有可能参加医疗保险优势计划.
- 研究结果表明,糖尿病患者自选进入MA.
- 对于糖尿病护理的FFS和MA之间的满意度没有显著差异,这意味着效果相似.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
697
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
697
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Carbohydrate Metabolism
11.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.8K
Diabetes: Management and Pharmacotherapy
399
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
399
Insulin: Dosing Regimen and Adverse Effects
262
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
262


